1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Gilquin, B. Roumestand, C. Zinn-Justin, S. Menez, A. Toma, F. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biopolymers BIPMAA 0161 0006-3525 33 1659 1675 10.1002/bip.360331104 8241426 Refined three-dimensional solution structure of a snake cardiotoxin: analysis of the side-chain organization suggests the existence of a possible phospholipid binding site. 1993 To be Published 0353 Proton NMR Studies of the Structural and Dynamical Effects of Chemical Modification of Single Aromatic Side Chain in a Snake Cardiotoxin 10.2210/pdb1cxo/pdb pdb_00001cxo 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 6838.462 CARDIOTOXIN GAMMA 1 man polymer no no LKCNQLIPPFWKTCPKGKNLCYKMTMRAAPMVPVKRGCIDVCPKSSLLIKYMCCNTDKCN LKCNQLIPPFWKTCPKGKNLCYKMTMRAAPMVPVKRGCIDVCPKSSLLIKYMCCNTDKCN A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n spitting cobra Naja sample 8654 Naja nigricollis database_2 pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Database references Derived calculations Other 1 0 1994-12-20 1 1 2008-03-24 1 2 2011-07-13 1 3 2022-02-16 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site Y BNL 1994-11-07 REL 9 BRUNGER refinement X-PLOR LEU 1 n 1 LEU 1 A LYS 2 n 2 LYS 2 A CYS 3 n 3 CYS 3 A ASN 4 n 4 ASN 4 A GLN 5 n 5 GLN 5 A LEU 6 n 6 LEU 6 A ILE 7 n 7 ILE 7 A PRO 8 n 8 PRO 8 A PRO 9 n 9 PRO 9 A PHE 10 n 10 PHE 10 A TRP 11 n 11 TRP 11 A LYS 12 n 12 LYS 12 A THR 13 n 13 THR 13 A CYS 14 n 14 CYS 14 A PRO 15 n 15 PRO 15 A LYS 16 n 16 LYS 16 A GLY 17 n 17 GLY 17 A LYS 18 n 18 LYS 18 A ASN 19 n 19 ASN 19 A LEU 20 n 20 LEU 20 A CYS 21 n 21 CYS 21 A TYR 22 n 22 TYR 22 A LYS 23 n 23 LYS 23 A MET 24 n 24 MET 24 A THR 25 n 25 THR 25 A MET 26 n 26 MET 26 A ARG 27 n 27 ARG 27 A ALA 28 n 28 ALA 28 A ALA 29 n 29 ALA 29 A PRO 30 n 30 PRO 30 A MET 31 n 31 MET 31 A VAL 32 n 32 VAL 32 A PRO 33 n 33 PRO 33 A VAL 34 n 34 VAL 34 A LYS 35 n 35 LYS 35 A ARG 36 n 36 ARG 36 A GLY 37 n 37 GLY 37 A CYS 38 n 38 CYS 38 A ILE 39 n 39 ILE 39 A ASP 40 n 40 ASP 40 A VAL 41 n 41 VAL 41 A CYS 42 n 42 CYS 42 A PRO 43 n 43 PRO 43 A LYS 44 n 44 LYS 44 A SER 45 n 45 SER 45 A SER 46 n 46 SER 46 A LEU 47 n 47 LEU 47 A LEU 48 n 48 LEU 48 A ILE 49 n 49 ILE 49 A LYS 50 n 50 LYS 50 A TYR 51 n 51 TYR 51 A MET 52 n 52 MET 52 A CYS 53 n 53 CYS 53 A CYS 54 n 54 CYS 54 A ASN 55 n 55 ASN 55 A THR 56 n 56 THR 56 A ASP 57 n 57 ASP 57 A LYS 58 n 58 LYS 58 A CYS 59 n 59 CYS 59 A ASN 60 n 60 ASN 60 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N CYS 3 A N CYS 3 A O LYS 12 A O LYS 12 A O ILE 39 A O ILE 39 A N LEU 20 A N LEU 20 A N THR 25 A N THR 25 A O LYS 50 A O LYS 50 1 -7.39 1.00 110.10 102.71 A A A CG CD1 NE1 TRP TRP TRP 11 11 11 N 1 8.08 0.90 109.00 117.08 A A A CD1 NE1 CE2 TRP TRP TRP 11 11 11 N 1 9.22 1.10 130.40 139.62 A A A NE1 CE2 CZ2 TRP TRP TRP 11 11 11 N 1 -6.28 1.00 107.30 101.02 A A A NE1 CE2 CD2 TRP TRP TRP 11 11 11 N 2 -6.79 1.00 110.10 103.31 A A A CG CD1 NE1 TRP TRP TRP 11 11 11 N 2 7.88 0.90 109.00 116.88 A A A CD1 NE1 CE2 TRP TRP TRP 11 11 11 N 2 10.03 1.10 130.40 140.43 A A A NE1 CE2 CZ2 TRP TRP TRP 11 11 11 N 2 -6.67 1.00 107.30 100.63 A A A NE1 CE2 CD2 TRP TRP TRP 11 11 11 N 3 -7.37 1.00 110.10 102.73 A A A CG CD1 NE1 TRP TRP TRP 11 11 11 N 3 8.20 0.90 109.00 117.20 A A A CD1 NE1 CE2 TRP TRP TRP 11 11 11 N 3 9.77 1.10 130.40 140.17 A A A NE1 CE2 CZ2 TRP TRP TRP 11 11 11 N 3 -6.62 1.00 107.30 100.68 A A A NE1 CE2 CD2 TRP TRP TRP 11 11 11 N 3 26.76 2.70 111.00 137.76 A A A N CA C VAL VAL VAL 32 32 32 N 4 -7.55 1.00 110.10 102.55 A A A CG CD1 NE1 TRP TRP TRP 11 11 11 N 4 8.40 0.90 109.00 117.40 A A A CD1 NE1 CE2 TRP TRP TRP 11 11 11 N 4 11.27 1.10 130.40 141.67 A A A NE1 CE2 CZ2 TRP TRP TRP 11 11 11 N 4 -7.18 1.00 107.30 100.12 A A A NE1 CE2 CD2 TRP TRP TRP 11 11 11 N 4 -5.75 0.90 133.90 128.15 A A A CG CD2 CE3 TRP TRP TRP 11 11 11 N 5 -7.45 1.00 110.10 102.65 A A A CG CD1 NE1 TRP TRP TRP 11 11 11 N 5 8.14 0.90 109.00 117.14 A A A CD1 NE1 CE2 TRP TRP TRP 11 11 11 N 5 9.68 1.10 130.40 140.08 A A A NE1 CE2 CZ2 TRP TRP TRP 11 11 11 N 5 -6.46 1.00 107.30 100.84 A A A NE1 CE2 CD2 TRP TRP TRP 11 11 11 N 6 -7.33 1.00 110.10 102.77 A A A CG CD1 NE1 TRP TRP TRP 11 11 11 N 6 8.03 0.90 109.00 117.03 A A A CD1 NE1 CE2 TRP TRP TRP 11 11 11 N 6 9.64 1.10 130.40 140.04 A A A NE1 CE2 CZ2 TRP TRP TRP 11 11 11 N 6 -6.33 1.00 107.30 100.97 A A A NE1 CE2 CD2 TRP TRP TRP 11 11 11 N 6 7.87 1.10 114.20 122.07 A A A CA CB SG CYS CYS CYS 54 54 54 N 6 6.84 1.10 114.20 121.04 A A A CA CB SG CYS CYS CYS 59 59 59 N 7 -6.87 1.00 110.10 103.23 A A A CG CD1 NE1 TRP TRP TRP 11 11 11 N 7 7.88 0.90 109.00 116.88 A A A CD1 NE1 CE2 TRP TRP TRP 11 11 11 N 7 9.07 1.10 130.40 139.47 A A A NE1 CE2 CZ2 TRP TRP TRP 11 11 11 N 7 -6.24 1.00 107.30 101.06 A A A NE1 CE2 CD2 TRP TRP TRP 11 11 11 N 8 -6.31 1.00 110.10 103.79 A A A CG CD1 NE1 TRP TRP TRP 11 11 11 N 8 7.56 0.90 109.00 116.56 A A A CD1 NE1 CE2 TRP TRP TRP 11 11 11 N 8 9.41 1.10 130.40 139.81 A A A NE1 CE2 CZ2 TRP TRP TRP 11 11 11 N 8 -6.22 1.00 107.30 101.08 A A A NE1 CE2 CD2 TRP TRP TRP 11 11 11 N 9 -6.87 1.00 110.10 103.23 A A A CG CD1 NE1 TRP TRP TRP 11 11 11 N 9 7.96 0.90 109.00 116.96 A A A CD1 NE1 CE2 TRP TRP TRP 11 11 11 N 9 9.73 1.10 130.40 140.13 A A A NE1 CE2 CZ2 TRP TRP TRP 11 11 11 N 9 -6.54 1.00 107.30 100.76 A A A NE1 CE2 CD2 TRP TRP TRP 11 11 11 N 1 A GLN 5 -103.86 -110.00 1 A LEU 6 -66.56 -86.10 1 A PRO 8 -65.28 -174.14 1 A PHE 10 -24.37 76.58 1 A LYS 18 -87.85 45.65 1 A MET 31 -158.57 65.80 1 A VAL 34 -138.27 -38.91 1 A ARG 36 -173.52 145.31 1 A PRO 43 -59.18 -178.37 1 A LYS 58 70.55 -25.73 1 A CYS 59 -54.57 1.23 2 A GLN 5 -108.77 -101.43 2 A LEU 6 -103.17 -95.72 2 A ILE 7 -80.19 -77.47 2 A LYS 18 -86.37 41.68 2 A MET 31 -154.68 64.57 2 A ILE 39 -124.67 -152.17 2 A PRO 43 -51.35 173.50 2 A SER 45 -55.99 97.37 2 A CYS 54 -170.35 -177.05 2 A LYS 58 65.63 -23.74 3 A GLN 5 -98.14 -119.52 3 A LEU 6 -52.29 -100.18 3 A PRO 8 -45.49 -173.86 3 A PHE 10 -3.51 69.82 3 A PRO 30 -59.49 -85.48 3 A PRO 33 -62.55 91.94 3 A ARG 36 -175.52 135.56 3 A ILE 39 -125.25 -157.42 3 A PRO 43 -75.41 -165.15 3 A LYS 44 -67.06 97.37 3 A LYS 58 67.79 -24.23 4 A CYS 3 -138.11 -147.17 4 A LEU 6 -129.37 -56.32 4 A ILE 7 -107.77 -145.09 4 A PRO 8 -36.00 154.08 4 A TRP 11 -156.00 -26.14 4 A LYS 12 -55.02 172.02 4 A LYS 18 -84.87 32.32 4 A MET 31 -158.11 66.84 4 A PRO 33 -65.13 98.50 4 A ARG 36 -171.24 141.55 4 A ILE 39 -118.18 -161.04 4 A ASP 40 -142.62 -51.12 4 A LYS 58 70.67 -24.15 5 A GLN 5 -105.46 -124.45 5 A LEU 6 -50.30 -101.53 5 A ILE 7 -122.92 -51.81 5 A PHE 10 174.99 74.57 5 A ALA 29 -160.42 -153.73 5 A VAL 32 -46.87 -160.47 5 A PRO 33 -49.00 100.28 5 A VAL 34 -143.48 -29.58 5 A PRO 43 -75.29 -165.30 5 A CYS 54 -162.98 -163.70 5 A LYS 58 69.20 -23.95 5 A CYS 59 -54.89 -0.08 6 A LEU 6 41.23 -145.37 6 A ILE 7 -96.52 -84.45 6 A LYS 18 -88.52 45.84 6 A ASN 19 -87.78 40.05 6 A ALA 29 -160.42 -37.29 6 A PRO 33 -69.49 99.19 6 A VAL 34 -93.98 -73.54 6 A ILE 39 -132.37 -155.21 6 A ASP 40 -121.25 -60.53 6 A PRO 43 -55.85 172.78 6 A CYS 54 -166.25 -163.50 6 A ASN 55 -141.78 -32.89 6 A LYS 58 69.86 -26.22 7 A GLN 5 -137.16 -127.71 7 A LEU 6 -84.76 -89.59 7 A ILE 7 -79.21 -85.12 7 A PRO 8 -49.40 174.81 7 A LYS 16 -39.57 131.61 7 A LYS 18 -91.18 44.58 7 A ALA 29 -159.39 -154.02 7 A VAL 32 -50.01 -154.87 7 A PRO 33 -39.95 99.65 7 A VAL 34 -146.22 -39.92 7 A ILE 39 -125.95 -150.59 7 A ASP 40 -125.03 -59.66 7 A PRO 43 -55.19 176.93 7 A SER 45 -70.00 97.50 7 A CYS 54 -173.59 143.21 7 A LYS 58 72.44 -26.43 8 A GLN 5 -95.35 -127.18 8 A LEU 6 -66.89 -126.20 8 A PRO 8 -44.00 167.81 8 A ASN 19 -84.40 32.56 8 A LYS 23 -174.23 -146.53 8 A ALA 29 -104.22 -158.06 8 A PRO 30 -67.19 -79.50 8 A MET 31 -155.66 64.65 8 A PRO 33 -67.35 91.23 8 A ARG 36 -160.55 107.46 8 A ILE 39 -137.04 -155.29 8 A ASP 40 -113.34 -70.17 8 A CYS 42 -38.67 116.31 8 A ASP 57 -46.72 151.89 8 A LYS 58 66.51 -24.54 8 A CYS 59 -57.06 -1.33 9 A LEU 6 -146.17 -122.69 9 A ILE 7 -91.64 -61.01 9 A PRO 9 -51.49 6.13 9 A LYS 16 -40.51 102.97 9 A LYS 18 -125.14 -126.81 9 A ASN 19 -148.61 36.61 9 A PRO 30 -59.53 -70.19 9 A MET 31 -157.31 66.97 9 A VAL 34 -145.92 -49.81 9 A ILE 39 -135.31 -152.23 9 A ASP 40 -123.77 -63.64 9 A PRO 43 -75.84 -167.68 9 A LYS 58 65.00 -21.66 model building X-PLOR refinement X-PLOR phasing X-PLOR REFINED THREE-DIMENSIONAL SOLUTION STRUCTURE OF A SNAKE CARDIOTOXIN: ANALYSIS OF THE SIDE-CHAIN ORGANISATION SUGGESTS THE EXISTENCE OF A POSSIBLE PHOSPHOLIPID BINDING SITE 1 Y N disulf 2.019 A CYS 3 A SG CYS 3 1_555 A CYS 21 A SG CYS 21 1_555 disulf 2.020 A CYS 14 A SG CYS 14 1_555 A CYS 38 A SG CYS 38 1_555 disulf 2.016 A CYS 42 A SG CYS 42 1_555 A CYS 53 A SG CYS 53 1_555 disulf 2.018 A CYS 54 A SG CYS 54 1_555 A CYS 59 A SG CYS 59 1_555 CYTOTOXIN CYTOTOXIN CX1_NAJPA UNP 1 1 P01468 LKCNQLIPPFWKTCPKGKNLCYKMTMRAAPMVPVKRGCIDVCPKSSLLIKYMCCNTDKCN 1 60 1CXO 1 60 P01468 A 1 1 60 2 3 anti-parallel anti-parallel anti-parallel A LYS 2 A LYS 2 A ASN 4 A ASN 4 A TRP 11 A TRP 11 A THR 13 A THR 13 A VAL 32 A VAL 32 A ILE 39 A ILE 39 A LEU 20 A LEU 20 A MET 26 A MET 26 A ILE 49 A ILE 49 A CYS 54 A CYS 54 1 P 1